Contest

Third annual JBC Methods Madness tournament

Make your predictions by March 6 for a chance to win a $100 gift card
Stephanie Paxson
Feb. 25, 2022

Calling all scientists! The Journal of Biological Chemistry’s third annual Methods Madness tournament is finally here.

Last year’s tournament stirred up quite the rivalry, with #TeamMassSpec dethroning #TeamCryo as the #JBCMethodsMadness champion! This year we welcome new contenders, including #TeamFlow, #TeamMedicine and #TeamProtein. Will one of these newbies make it to the finals? You decide!

The madness begins on Monday, March 7. (See tournament schedule below.) Submit your bracket by Sunday, March 6, for a chance to win a $100 gift card. 

Round 1: The Scientific 16

Vote for your favorite methods by participating in polls posted by @jbiolchem.

Monday, March 7

9 a.m. – #TeamMassSpec vs. #TeamNMR

2 p.m. – #TeamXRC vs. #TeamImmuno

Tuesday, March 8

9 a.m. – #TeamChroma vs. #TeamFRET

2 p.m. – #TeamFlow vs. #TeamPCR

Wednesday, March 9

9 a.m. – #TeamCRISPR vs. #TeamOmics

2 p.m. – #TeamSuperRes vs. #TeamOpto

Thursday, March 10

9 a.m. – #TeamCryo vs. #TeamMedicine

2 p.m. – #TeamLiveCell vs. #TeamProtein

All times Eastern.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Stephanie Paxson

Stephanie Paxson is the ASBMB’s journal marketing associate.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.